Introduction
Human Papillomaviruses (HPVs) are small double-stranded DNA viruses that infect mucosa and cutaneous epithelium, and the more than 100 genotypes of HPVs are divided into five genera. The alpha genus of HPV is further subdivided into HPV types termed low risk (LR HPV), which are associated with genital warts and benign lesions, and high risk (HR HPV), which can cause anogenital cancers. A long-term, persistent infection with a HR HPV type is the greatest risk factor for cervical cancer development (Moscicki et al., 2012; Rodriguez et al., 2010; Kjaer et al., 2002) , and therefore the manner by which HR HPV persists and dysregulates its host cell, leading to cancer, is a focus of intensive research.
HPV depends upon both epithelial differentiation and continued cell cycling to complete its life cycle, and these processes are regulated by both the host cell and the virus (reviewed in (Doorbar et al., 2012) ). HPV first infects the basal layer of stratified squamous epithelium, typically through micro-abrasions or anatomic epithelial transitions that expose these cells. Once the virus infects a basal cell, the episomal viral DNA migrates to the nucleus and is maintained at low copy numbers initially in proliferative epithelial cells while viral early proteins are expressed. As epithelial cells migrate to upper layers of stratified squamous epithelium, the expression of late viral proteins is induced, and the viral genome becomes amplified to thousands of copies per cell. Finally, virion assembly is coupled to late cellular differentiation, and infectious virus is released as host epithelial cells slough off. Despite our understanding of the normal HPV viral life cycle and normal epithelial differentiation, the molecular events that directly regulate the switch from viral genome maintenance to viral genome amplification and productive infection in an HPVinfected cell are not well understood, nor are the HPV-driven disruptions of epithelial differentiation, cell cycling, and cellular arrest pathways.
HR HPV type 16 (HPV 16) encodes two viral oncoproteins: E6 and E7. These oncoproteins perturb apoptosis and senescence by degradation of tumor suppressors p53 and Rb, dysregulation of angiogenesis, and modulation of keratinocyte growth and differentiation. HPV 16E6 specifically partners with cellular proteins to alter multiple epithelial and oncogenic pathways. One host cell protein bound by 16E6 is the cytoplasmic protein NFX1-123 (Katzenellenbogen et al., 2007) . NFX1-123 increases telomerase activity through post-transcriptional gene upregulation in HPV 16E6 expressing human foreskin keratinocytes (HFKs) (Katzenellenbogen et al., 2009; Katzenellenbogen et al., 2007) . Recently, our laboratory Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/yviro showed that NFX1-123 also synergizes with 16E6 to modulate Notch1 protein and mRNA expression (Vliet-Gregg et al., 2013) . Both telomerase and Notch1 are important regulators of cellular senescence, growth, and differentiation.
The mammalian Notch gene family encodes evolutionarily conserved type 1 transmembrane receptors that play a key role in cell fate determination and differentiation through cell-cell communication (Borggrefe and Oswald, 2009; Watt et al., 2008) . The Notch family of cell surface receptors is comprised of four transmembrane proteins (Notch1 to Notch4). In keratinocytes, Notch1 and Notch2 are primarily expressed. During canonical Notch1 signaling, ligands belonging to the Delta or Serrate/Jagged family bind the Notch receptor, and the receptor is cleaved by the gamma-secretase protease complex, releasing the Notch intracellular domain (NICD), to translocate to the nucleus (Watt et al., 2008) . In the nucleus, NICD associates with the DNA binding protein RBP-J (also known as CBF1) and its transcriptional coactivator Mastermind (MAML), activating downstream targets such as HES and HEY family members (Watt et al., 2008) . Notch1 signaling has been identified as both oncogenic and tumor suppressive in cervical cancer development and progression, dependent on the experimental design and cellular context (Yugawa et al., 2007; Veeraraghavalu et al., 2004; Bajaj et al., 2011; Henken et al., 2012; Lathion et al., 2003; Maliekal et al., 2008; Talora et al., 2002; Weijzen et al., 2003; Yugawa et al., 2010; Zagouras et al., 1995) .
In the present study, we investigate the roles Notch1 and NFX1-123 each play in Notch canonical pathway regulation, differentiation pathway regulation, and cellular growth and cycling in 16E6 HFKs. Endogenous NFX1-123 is expressed to a greater degree in HPV positive cervical cancer cell lines than in HFKs, and when 16E6 HFKs are transduced to overexpress NFX1-123, we found NFX1-123 had dual modes of action on the Notch canonical pathway and the differentiation pathway. In these 16E6 HFKs, increased NFX1-123 expression led to an augmented activation of canonical pathway genes Hes1 and Hes5, and this occurred directly through the Notch1 receptor. We also discovered that overexpressed NFX1-123 upregulated the gene expression of differentiation gene markers Keratin 1 and Keratin 10. However, this increase in differentiation gene expression in 16E6 HFKs with overexpressed NFX1-123 did not parallel the kinetics and magnitude of Notch canonical pathway gene activation, nor did it depend fully on the Notch1 receptor. Finally, the enhancement of the Notch canonical pathway and differentiation gene expression did not trigger the expected concomitant increase in cell cycle arrest or decrease in growth factor gene expression. The distinct activation of Notch canonical pathway genes and differentiation pathway genes by overexpressed NFX1-123 leads to a model of direct and indirect pathway regulation, respectively. It also highlights an uncoupling of keratinocyte differentiation from cell cycle exit in 16E6 HFKs through NFX1-123 overexpression, an unusual cellular phenotypic state that may support HPV persistence and cancer progression.
Results

NFX1-123 expression increased in cervical cancer cell lines
NFX1-123 and 16E6 and collaboratively regulate hTERT and Notch1 expression (Katzenellenbogen et al., 2007; Vliet-Gregg et al., 2013; Katzenellenbogen et al., 2009) , and both hTERT and Notch1 drive cellular growth and malignant transformation (Katzenellenbogen et al., 2010; Henken et al., 2012) . As hTERT and Notch1 can be increased in cervical cancer development and progression, we hypothesized that NFX1-123 may also be increased in HPV positive cervical cancer cell lines. Indeed, SiHa, CaSki, and HeLa cell lines all had increased protein and mRNA NFX1-123 expression ( Fig. 1A and  B) . Therefore, because NFX1-123 levels were increased, we chose to study further how a gain in NFX1-123 expression in 16E6 HFKs would affect downstream Notch canonical, growth, and differentiation pathways.
NFX1-123 and Notch1 regulation of canonical pathway genes in 16E6 HFKs
We previously published that Notch1 expression was modulated by the level of NFX1-123 in HFKs; 16E6 synergistically increased or decreased Notch1 dependent on the amount of NFX1-123 expressed (Vliet-Gregg et al., 2013) . Multiple components of the Notch canonical pathway, like Hes1 and Hes5, were increased in 16E6 HFKs with greater NFX1-123, and were reduced when NFX1-123 was knocked down by short-hairpin RNA (Vliet-Gregg et al., 2013) . Whether NFX1-123 drove expression of Hes1 and Hes5 directly itself or through Notch1 and its canonical signaling pathway was unclear, however.
To determine this, the Notch1 receptor was either blocked or activated using the gamma secretase inhibitor DAPT or the ligand Delta-Ligand 1 (DL1), respectively. This was done in 16E6 HFKs transduced to overexpress NFX1-123 (16E6/FNFX1-123WT) or vector control (16E6/LXSN), noting that 16E6/FNFX1-123WT HFKs had increased Notch1 when compared to 16E6/LXSN HFKs (Vliet-Gregg et al., 2013) . Cells were treated with DAPT to block cleavage of membrane-bound Notch to its active, intracellular form. Cleaved Notch1 (or NICD) was undetectable by whole cell extract immunoblot assay in both 16E6/FNFX1-123WT and 16E6/LXSN HFKs within one hour of treatment when compared to vehicle control (dimethyl sulfoxide (DMSO)) ( Fig. 2A) . With DMSO treatment, 16E6/FNFX1-123WT HFKs had eightfold greater Hes1 mRNA and threefold greater Hes5 mRNA when compared to 16E6 HFKs with endogenous levels of NFX1-123 (16E6/LXSN) ( Fig. 2B and C) . However, when Notch1 cleavage was blocked by DAPT, Hes1 and Hes5 mRNA in 16E6/FNFX1-123WT HFKs rapidly returned to amounts equivalent to 16E6/LXSN HFKs ( Fig. 2B and C) . Notch1 mRNA itself was increased eightfold in DMSO-treated 16E6/FNFX1-123WT HFKs versus 16E6/ LXSN HFKs; this too was reduced by more than half with DAPT treatment (Fig. 2D ). Without cleavage of Notch1 to its active intracellular form, the sustained increase of Hes1, Hes5 and Notch1 mRNA in 16E6/FNFX1-123WT cells fell to the level of 16E6/LXSN HFKs ( Fig. 2B-D , DMSO vs DAPT 3 h).
The Notch1 receptor was then activated by culturing 16E6/ FNFX1-123WT or 16E6/LXSN HFKs in the presence of Delta-1 ligand (DL1) immobilized with retronectin or retronectin alone. Ligand immobilization with retronectin is required for Notch signal induction by DL1 (Varnum-Finney et al., 2000) , with DL1 triggering Notch1 receptor activation and subsequent cleavage to its intracellular, active form (NICD). Hes1 and Hes5 expression had a robust and rapid induction in response to Notch1 receptor activation by DL1, increasing within three hours. In 16E6/FNFX1-123WT cells this mRNA increase was more than sixty times greater for Hes1 and thirty times higher for Hes5 than in 16E6/LXSN HFKs ( Fig. 3A and B) . Notch1 mRNA also increased more than two hundredfold within three hours of culture with DL1 ( Fig. 3C and  D) . Notch1, Hes1 and Hes5 mRNA did increase in 16E6/LXSN HFKs cultured with DL1, but this did not occur until 24 h (Fig. 3A-C) . Therefore, when triggered by DL1, increased NFX1-123 and Notch1 expression in 16E6/FNFX1-123WT HFKs led to greater and more rapid induction of Hes1, Hes5, and Notch1 when compared to 16E6/LXSN cells. Using retronectin without DL1, there was no change in Hes1, Hes5, or Notch1 transcript levels in 16E6/LXSN HFKs, but in 16E6/FNFX1-123WT HFKs where Notch1 is persistently increased, there were modest increases in Hes1, Hes5, and Notch1 mRNA levels ( Fig. 3A-D) . These Notch canonical pathway studies, where Notch1 receptor was blocked or activated collectively, support the conclusion that NFX1-123 requires Notch1 itself to drive expression of Hes1 and Hes5, and when NFX1-123 itself is overexpressed it leads to a sustained greater Notch1 expression and therefore more dramatic and rapid activation or reduction in Notch canonical pathway targets.
Differentiation gene expression but not p21WAF1/Cip1 increased by NFX1-123 in 16E6 HFKs
We previously conducted a microarray study to determine genes modulated by NFX1-123 in 16E6 HFKs (Vliet-Gregg et al., 2013) . Data from this microarray study, analyzed using Gene Ontology terms for Biological Process classification, revealed that epidermal and keratinocyte differentiation were pathways significantly perturbed through NFX1-123 overexpression in 16E6 HFKs when compared to an isogenic scramble shRNA control (Fig. 4A) . Genes found to be increased twofold or more by microarray analysis that supported these identified pathway changes included the keratinocyte differentiation markers late cornified envelope proteins (LCEs), loricrin, and small proline rich proteins (SPRRs) (noted in model, Fig. 4B ) (Vliet-Gregg et al., 2013) . Because the epidermal and keratinocyte differentiation pathways were significantly upregulated in the microarray study, we chose to quantify gene expression changes of several markers that should be increased during keratinocyte differentiation: Keratin 1 and Keratin 10 (early markers of differentiation in stratified squamous epithelium), and Loricrin (increased in our microarray) (underlined in Fig. 4B ) (Vliet-Gregg et al., 2013) . FNFX1-123WT HFKs with no 16E6 co-expression had only a subtle increase in Keratin 1 mRNA, one-and-a-halffold, when compared to isogenic scramble shRNA control cells (scramble). Keratin 10 and Loricrin mRNA were moderately increased, up to fourfold in these cells (Fig. 4C , left panel). These genes in 16E6/FNFX1-123WT HFKs revealed enhanced expression, seven-to-thirtyfold, of Keratin 1, Keratin 10 and Loricrin mRNA compared to 16E6/scramble cells (Fig. 4C , right panel). Therefore, 16E6 co-expression led to greater levels of Keratin 1, Keratin 10, and Loricrin in HFKs with overexpressed NFX1-123.
Surprisingly, while mRNA expression of differentiation marker genes were increased and differentiation pathways were significantly altered when NFX1-123 was overexpressed in 16E6 HFKs, genes involved in cell cycle regulation were unperturbed. We found no evidence for increases in cell cycle arrest genes by microarray (Vliet-Gregg et al., 2013) or subsequent Gene Ontology analyses. To confirm this, we quantified the expression of p21
, a cell cycle arrest gene. The p21 WAF1/Cip1 gene is directly activated by p53 and by Notch1 Warfel and El-Deiry, 2013 ) to trigger cell cycle arrest. It is known that p21 WAF1/Cip1 expression is reduced in 16E6 expressing cells through p53 degradation and inactivation of the p150 transcription factor (Huibregtse et al., 1991; Parroche et al., 2011; Scheffner et al., 1993) . We wanted to determine if 16E6 affected p21 WAF1/Cip1 levels in cells overexpressing NFX1-123, and if p21 WAF1/ Cip1 levels were modulated by the augmented Notch1 expression in 16E6/FNFX1-123WT HFKs. As expected, p21 WAF1/Cip1 mRNA was detected in vector control (pBABE) HFKs, and it was reduced by half when 16E6 was expressed (Fig. 4D) . In 16E6/FNFX1-123WT HFKs there was no change in p21 WAF1/Cip1 mRNA expression when compared to 16E6/LXSN HFKs (Fig. 4D ), despite greater Notch1 and differentiation gene expression (Vliet-Gregg et al., 2013) and Figs. 2-4. We also found no change in Cyclin A, B1, or E protein expression in 16E6/FNFX1-123WT HFKs when compared to cells with endogenous levels of NFX1-123 (Fig. 4E ). Higher levels of NFX1-123 (FNFX1-123WT) increased keratinocyte differentiation gene expression and was further increased by 16E6 co-expression in HFKs, but surprisingly this was not accompanied by concomitant cell cycle arrest or senescence as marked by p21 WAF1/Cip1 expression.
Regulation of differentiation and cell cycle arrest pathway genes by NFX1-123 and Notch1 in 16E6 HFKs
Notch1 functions as a master regulator of growth and differentiation in keratinocytes and during cervical cancer development (Maliekal et al., 2008; Henken et al., 2012; Lathion et al., 2003; Rangarajan, Syal et al., 2001; Zagouras et al., 1995) . Because NFX1-123 increases Notch1 expression in 16E6 HFKs, and greater levels of Notch1 may drive increased differentiation marker expression and pathway activation, it was important to determine if increased differentiation gene expression and pathway changes in 16E6/FNFX1-123WT HFKs occurred directly via Notch1 receptor activation, similar to the Notch canonical pathway genes Hes1 and Hes5. As a corollary, we wanted to elucidate whether activation or blockade of the Notch1 receptor in 16E6/FNFX1-123WT and 16E6/LXSN HFKs led to interlinked regulation of differentiation and cell cycle arrest or whether they were fully uncoupled.
To explore this, we expanded on our previous studies and treated 16E6/FNFX1-123WT or 16E6/LXSN HFKs with DAPT to block Notch1 receptor cleavage and activation, and serially collected lysates for quantitation of both differentiation and cell cycle arrest genes. The profile of Keratin 1 and Keratin 10 mRNA changes did not parallel those of the Notch1 canonical pathway genes Hes1 and Hes5 (compare Fig. 2B and C and Fig. 5A and B) . In both 16E6/ FNFX1-123WT and 16E6/LXSN HFKs, there was no decrease in differentiation marker gene expression with inhibition of Notch1 activation. In fact, at three hours of DAPT treatment in 16E6/LXSN HFKs, the transcript levels of Keratin 1 and Keratin 10 increased ( Fig. 5A and B) . Furthermore, the cell cycle arrest gene p21 WAF1/Cip1 mRNA was unchanged when Notch1 cleavage was blocked (Fig. 5C ). When later time points were evaluated, no decrease or increase in Keratin 1, Keratin 10 or p21 WAF1/Cip1 mRNA levels was identified (data not shown). Therefore, differentiation marker and cell cycle arrest gene expression did not depend on activated, cleaved Notch1 in either 16E6 cell type. When Notch1 receptor was activated by immobilized DL1, Keratin1 and Keratin 10 increased, but the kinetics of their increased expression were dramatically different than the Notch canonical pathway target genes Hes1 and Hes5 (compare Fig. 6 and Fig. 3) . At three hours, Keratin 1 and Keratin 10 had a less robust increase in expression that continued to rise at 24 h, unlike Hes1 and Hes5 (Fig. 6A and B) . Also, only 16E6/FNFX1-123WT HFKs had an increase in Keratin 1 and Keratin 10 levels when activated by DL1, as those cells had greater baseline Notch1 expression. Finally, we found p21 WAF1/Cip1 mRNA fell over the course of DL1 activation (Fig. 6C) . So, Notch1 activation by DL1 did slowly lead to moderate increases in differentiation gene expression, but only in cells with greater Notch1 expression (16E6/FNFX1-123WT HFKs, Fig. 6 vertical striped bars), and activation of Notch1 did not trigger increased p21 WAF1/Cip1 expression. 
No growth suppression with increased differentiation gene expression by NFX1-123 in 16E6 HFKs
Higher NFX1-123 and Notch1 protein and mRNA expression did not increase the cell cycle arrest gene p21 WAF1/Cip1 in 16E6 HFKs (Figs. 4D and 6C ) However, we wanted to assess if other genes involved in growth or proliferation were repressed, leading to slowed growth or cell cycle blockade in 16E6/FNFX1-123WT HFKs compared to 16E6/LXSN HFKs. Additionally, there may be subsets of 16E6/FNFX1-123WT HFKs that express greater amounts of differentiation markers and concomitantly do not express proliferation markers, but this difference was undetectable when averaged across a population of cells. To address these issues, we quantified differentiation gene and growth marker expression on a cell-by-cell basis in 16E6/FNFX1-123WT and 16E6/LXSN HFKs. To evaluate whether there were differences in cell growth and proliferation factor expression in cells with greater NFX1-123, 16E6/FNFX1-123WT and 16E6/LXSN HFKs were stained for Ki67.
We found 96% of 16E6/LXSN HFKs to be Ki67 positive, and this remained unchanged when NFX1-123 was overexpressed (16E6/ FNFX1-123WT) ( Fig. 7A and B) . Therefore equal numbers of 16E6 HFKs expressed Ki67 irrespective of NFX1-123 levels. These cells were then co-stained for Keratin 1 and Ki67 to assess whether there were cells with greater differentiation marker gene expression that segregated into separate populations from cells with growth factor expression. Keratin 1 protein expression was nearly twofold greater in 16E6/FNFX1-123WT HFKs than in 16E6/LXSN HFKs, and its staining was homogeneous across the cell population ( Fig. 7C and D) . Again, as in Fig. 7A and B, more than 95% of 16E6 HFKs expressed Ki67 regardless of the expression level of NFX1-123 or Keratin 1 (Fig. 7C and D) . Therefore, nearly all 16E6 HFKs with increased NFX1-123 still expressed a proliferation factor, Ki67, even as NFX1-123, Notch1, and differentiation markers, such as Keratin 1, were increased.
Normal cell cycle progression in 16E6 HFKs with increased NFX1-123
Even with similar p21 WAF1/Cip1 and Ki67 expression in 16E6/ FNFX1-123WT and 16E6/LXSN HFKs, the rate of cell cycle progression in 16E6/FNFX1-123WT HFKs might be slowed with both increased Notch1 and differentiation pathway gene expression. We performed cell cycle analysis using fluorescence-activated cell sorting to compare the cell cycle profiles of density arrested and released 16E6/FNFX1-123WT HFKs to 16E6/LXSN HFKs. Interestingly both of these cell types were cycling, and there was no slowing in 16E6/FNFX1-123WT HFKs (Fig. 8A) . In fact, a greater fraction of 16E6/FNFX1-123WT HFKs were already in G2 at four hours after release when compared to 16E6/LXSN, and by six hours, a greater number of 16E6/FNFX1-123WT HFKs had returned to G1 when compared to 16E6/LXSN HFKs (Fig. 8B ). 16E6 HFKs with overexpressed NFX1-123 had increased Notch1, canonical pathway, and differentiation gene expression but had uncoupled the typical reflexive activation of cell cycle arrest shown by unchanged p21, Ki67, and cell cycle profiles.
Discussion
These studies identified a separation in gene and pathway regulation for 16E6 HFKs with increased expression of NFX1-123. In 16E6 HFKs, Notch1, Notch canonical pathway genes Hes1 and Hes5, and differentiation pathway genes Keratin 1 and Keratin 10 were all altered by greater NFX1-123 expression. However, NFX1-123 in these cells did not increase p21 WAF1/Cip1 mRNA, change Ki67 expression, or cause cell cycle arrest. These findings lead to a dualfaceted model of pathway regulation by NFX1-123 and Notch1 in 16E6 HFKs (Fig. 9 ). NFX1-123 regulates Notch1 expression in an augmented manner in 16E6 cells. When the Notch1 receptor is activated by DL1, Hes1, Hes5, and Notch1 mRNA expression quickly increase (Fig. 3) . This first mode of action on the canonical pathway is rapid, suggesting that the effect is directly due to Notch1 and NFX1-123. Consistent with this, when the Notch1 receptor cleavage and activation was blocked by gamma secretase inhibitor, the increased expression of Hes1 and Hes5 mRNA fell rapidly to the level of 16E6 HFKs with endogenous expression levels of NFX1-123 (Fig. 2) . These data point again to NFX1-123 driving Hes1 and Hes5 expression through activated, cleaved Notch1. They also point to Notch1 regulating its own expression when it is cleaved and activated or chemically blocked (Fig. 2D, 3C and D) . We propose that the greater activation of Hes1, Hes5, and Notch1 expression in 16E6/FNFX1-123WT HFKs compared to 16E6/LXSN HFKs is due to the greater level of full length Notch1 found in these cells. With more Notch1 receptor available for activation by DL1, more cleaved Notch can be produced, leading to the direct, rapid, and robust downstream gene target response, and when Notch1 receptor is blocked, the fall in its downstream genes is also fast. Conversely, the differentiation pathway is regulated in 16E6 HFKs by NFX1-123 and Notch1 in a mode distinct from the canonical pathway. Keratin 1 and Keratin 10 mRNA expression are unperturbed by blocking cleavage of Notch1 in 16E6/FNFX1-123WT HFKs (Fig. 5) . However, when Notch1 was activated by DL1, Keratin 1 and Keratin 10 expression were increased in 16E6/ FNFX1-123WT HFKs (Fig. 6) . The activation profiles of these differentiation markers were more gradual and less robust than the canonical pathway genes, which depended on the overexpression of NFX1-123 and Notch1. Keratin 1 and Keratin 10 did not increase in 16E6 HFKs with endogenous levels of NFX1-123 and Notch1. In our model of 16E6 HFKs, Notch1 has an indirect effect on the differentiation pathway and its genes only when NFX1-123 is overexpressed. Green¼Ki67; Blue ¼DAPI; Red ¼Keratin 1. Similar results were observed in three independent experiments using three distinct 16E6 HFK cell lines. Finally, an uncoupling of Notch1 and differentiation pathway upregulation from growth arrest in 16E6 HFKs was also identified in our studies. There was no evidence of an upregulation in growth arrest genes in our microarray screen when 16E6 HFKs with overexpressed NFX1-123 were compared to those with endogenous levels of NFX1-123 (Vliet-Gregg et al., 2013). Additionally no difference was found in expression of p21 WAF1/Cip1 (Fig. 4) , despite it being a Notch1 regulated gene, and there was no decrease in percent of Ki67 expression in cells or cell cycle rates in 16E6/ FNFX1-123WT HFKs (Figs. 7 and 8 ). There was no heterogeneity in growth factor or differentiation gene expression among 16E6/FNFX1-123WT and 16E6/LXSN HFKs at a population level or on a cell-by-cell basis, and 16E6 HFKs with greater expression of NFX1-123 progressed normally through the cell cycle, if not faster than 16E6/LXSN HFKs. This suggests that 16E6 cells with greater NFX1-123 expression increase Notch pathway canonical and differentiation genes while concurrently avoiding cell cycle exit and growth arrest. It is well-known that HPV requires epithelial cells to both divide and differentiate during its viral life cycle, but it is less clear if cellular division and differentiation happen simultaneously within the same cell or whether these changes occur separately in distinct layers of stratified squamous epithelium. Recent studies support our findings and have found increased Notch1 expression co-occurring with both an increased growth potential and differentiation marker expression in cervical cancer cell lines as well as in HFKs expressing HPV 31 (Pattabiraman et al., 2014) . Additionally, the parsing of differentiation and growth arrest pathways has been seen in the context of 16E7 expression (Lefort et al., 2007; Muller et al., 1999; Nguyen et al., 2006) , so there is precedence for an HPV oncoprotein uncoupling differentiation from cellular growth.
The increases we found in differentiation pathway regulation by Gene Ontology (Fig. 4A) , and differentiation gene expression (Fig. 4C ) required greater NFX1-123 expression and were specifically augmented by 16E6 co-expression. In a microarray study we conducted of non-16E6 expressing HFKs, two differentiation genes had twofold or greater mRNA levels with overexpression of NFX1-123 alone (GEO (GSE43082)); these genes plus several more were increased when NFX1-123 was overexpressed and 16E6 was coexpressed (Vliet-Gregg et al., 2013) . These findings support a hypothesis that NFX1-123 regulates the keratinocyte differentiation pathway, and this is synergistically increased by 16E6 while avoiding changes to cell growth.
Greater NFX1-123 (typically overexpressed threefold in 16E6/ FNFX1-123WT HFKs) drives augmented hTERT expression and telomerase activity (Katzenellenbogen et al., 2007; Katzenellenbogen et al., 2009) , and clinically greater telomerase activity parallels worsening cervical disease (Ault t al., 2005; Branca et al., 2006) . Increased NFX1-123 expression may be an important driver of both telomerase activation and cellular dysregulation with high risk E6, and the combination of increased NFX1-123 with 16E6 affecting host cells' differentiation and growth pathways is important to study. Additional studies are on-going to examine the mechanism by which NFX1-123 and 16E6 increase differentiation gene expression collaboratively, the factors that link Notch1 and differentiation directly or indirectly through NFX1-123 and 16E6, and how these changes influence the HPV viral life cycle.
Conclusions
Our findings point to a model of keratinocytes where HR HPV oncogenes -specifically HPV 16E6 -and increased NFX1-123 lead to greater Notch1 and canonical pathway gene expression as well as differentiation pathway gene expression, while entirely untethering them from concomitant growth arrest. This cellular phenotype, driven by NFX1-123 expression, may lead to both growth and differentiation within the same cell and an ideal host cell environment for a longlived and productive HPV infection.
Material and methods
Microarray
Microarray analysis has been previously described and is accessible through GEO (GSE43082) (Vliet-Gregg et al., 2013) . Biological interpretation using Gene Ontology was performed using GeneSpring GX11.5.1 (Agilent Technologies, Santa Clara, CA).
Tissue culture
Primary human foreskin keratinocytes (HFKs) were cultured as described previously (Gewin et al., 2004) . Briefly, HFKs were derived from neonatal foreskins and grown in EpiLife medium supplemented with calcium chloride (60 μM), human keratinocyte growth supplement (Life Technologies, Carlsbad, CA), and penicillin-streptomycin. HFKs cultured for cyclin detection were treated with 10 mM of MG132 (Sigma, Saint Louis, MO), two hours prior to harvest of whole cell protein extracts. 293T cells were grown in Dulbecco's modified Eagle's medium (GIBCO-BRL, Carlsbad, CA) containing 10% fetal bovine serum and penicillin-streptomycin.
Retrovirus production and infection
Retrovirus was produced in 293T cells by a transient vesicular stomatitis virus G-pseudotyped virus (VSV-G) production protocol as previously described (Bartz and Vodicka, 1997) . Lentivirus was also produced as previous described (Katzenellenbogen et al., 2007) . Retrovirus and lentivirus was serially collected, concentrated by ultracentrifuge, mixed with Polybrene (8 μg/mL) (EMD Millipore, Billerica, MA), and incubated with 50 to 60% confluent HFKs. Three hours later, the Epilife medium was replaced. For VSV-G pseudotyped virus infections (FNFX1-123WT, LXSN vector control, pBabe-puro 16E6) the cells were expanded 24 h post-transduction, and after 48 h the cells were placed under neomycin/G418 selection (50 μg/ mL) or puromycin selection (0.5 μg/mL). All lentivirus infections (scramble) were confirmed by green fluorescent protein expression.
Quantitative real-time PCR and Taqman array
Total RNA was isolated with TRIzol reagent (Life Technologies, Carlsbad, CA). Total RNA (1 mg) was DNase treated and used to generate cDNA with random hexamer primers and SuperScript II reverse transcriptase (Life Technoloiges, Carlsbad, CA). Quantitative real-time PCR was performed using an ABI StepOne Plus system (Applied Biosystems, Foster City, CA). Amplification was carried out using TaqMan master mix and the following pre-designed Taqman probes: GAPDH (4333764F), KRT1 (Hs00196158_m1), KRT10 (Hs00166289), LOR (HS01894962_s1), Notch1 (HS01062014_m1), HES1 (Hs00172878_m1), and HES5 (Hs01387463_g1) according to the manufacturer's instructions (Applied Biosystems, Foster City, CA). Reactions were performed in triplicate. Data analysis was performed using the comparative threshold cycle method (Applied Biosystems, Foster City, CA) to determine relative expression levels, with GAPDH to normalize mRNA levels within each sample. Values graphed are the mean fold-change in each sample compared to control, and error bars graphed represent the standard deviation for each sample (n¼ 3). Primer sequences for NFX1-123, p21
Waf1/CIP1 and 36B4 were described previously (McDade et al., 2011; Katzenellenbogen et al., 2007) . Amplification was carried out as previously published (Katzenellenbogen et al., 2007) using Power Sybr Green Master Mix (Life Technologies, Foster City, CA. Error bars using NFX1-123, p21
Waf1/ CIP1 and 36B4 primers represent 95% confidence intervals.
Immunoblotting
Western Blots were performed as described previously (Vliet-Gregg et al., 2013) . Blots were probed with the following antibodies: actin (I-19) (1:1000; Scbt, Santa Cruz, CA), Cleaved Notch1 (Val1744) (1:1000; Cell Signaling, Danvers, MA), Cyclin A (H432) (1:500; Scbt, Santa Cruz, CA), Cyclin B1 (GNS1) (1:500; Scbt, Santa Cruz, CA), Cyclin E (C-19) (1:500; Scbt, Santa Cruz, CA), GAPDH (1:100,000, Abcam, Cambridge, MA) and Notch1 (5B5) (1:1000; Cell Signaling, Danvers, MA). The rabbit polyclonal anti-NFX1-123 antibody was generously provided by Dr. Ann Roman.
Immunofluorescence
16E6 HFK cell lines were cultured on glass coverslips and grown to 60% confluency as described previously (Katzenellenbogen et al., 2009) . Cells were then fixed with 4% paraformaldehyde, permeabilized and stained with Ki67 antibody VP-K451 (1:1000 for 60 min, Vector Laboratories, Burlingame, CA) and TO-PRO3 nuclear stain (Life Technologies, Carlsbad, CA), as previously described (Katzenellenbogen et al., 2009) . Confocal microscopy was conducted as previously described (Katzenellenbogen et al., 2009) . For the Ki67 expression rates, more than 700 cells for both LXSN-expressing and FLAG-NFX1-123-expressing HFKs were counted. Ki67 expression was determined manually, and the percent of Ki67þ cells (Ki67þ cells/total cells) and 95% confidence intervals were calculated using Excel (Redmond, WA).
Dual Immunohistochemistry
16E6 HFKs were grown in culture, rinsed with warm PBS, scraped off tissue culture plates, and centrifuged. The cell pellet was washed in PBS and resuspended in 10% neutral buffered formalin. The cell pellet was fixed for three to five days at 4 1C and embedded in paraffin for staining. Antigen was retrieved by Trilogy steamer for 20 min with a 20 min cool down. Cells were blocked with TCT Buffer and stained with Ki67 MIB1 (1:50 for 60 min; Dako M7240, Carpinteria, CA), Keratin 1 (1:200 for 60 min; Covance PRB-149 P, Princeton, NJ), or an isogenic IgG control. Cells were counterstained with DAPI. Confocal microscopy was conducted as previously described (Katzenellenbogen et al., 2009) . Mean gray scale value of Keratin 1 was quantified on Z-stack cell projections using ImageJ. Images were quantified after adjustment to isotype control threshold values.
Delta-1 ligand and gamma secretase inhibitor treatment
Chemical inhibition of Notch signaling was done by treating cells with 10 mM gamma secretase inhibitor IX, DAPT (DAPT, 565784, Millipore, Billerica, MA). Delta-1 ligand (DL1) was produced as previously described (Varnum-Finney et al., 2000) and was a generous gift from Dr. Colleen Delaney for Notch1 activation. Briefly, 2.5 mg/mL of DL1 and 5 mg/mL of retronectin [a vehicle that is required for immobilizing Delta-1 ligand to the non-coated tissue culture plate] or retronectin alone as a control (Takara/ Clontech, Mountain View, CA) were diluted in chilled PBS, coated onto non-tissue culture treated plates at 0.16 mL/cm 2 and kept overnight at 4 1C. Keratinocytes were then plated the following day after washing the plates with PBS. All experiments were done in keratinocytes at 50-60% confluency in culture because Notch signaling occurs between adjacent cells and cell-cell contact is an inducer of keratinocyte differentiation in culture. Keratinocytes used for these experiments were also of equivalent passages and were never cultured beyond passage 15.
Fluorescence-activated cell sorter (FACS) analysis
For the pulse chase experiments, cells were synchronized by growing to confluence and waiting an additional 24 h before release. Cells were released and labeled with 200 mM BrdU for one hour, chased in BrdU-free media, and collected at indicated times. Cells were harvested by trypsinization and pelleted by centrifugation. All centrifugation steps were done for five minutes at 1000g. Cell pellets were resuspended in cold phosphatebuffered saline (PBS); and while being vortexed, samples were fixed by the addition of cold 95% ethanol for overnight storage at 4 1C. Nuclei were isolated from fixed cells by incubating pellets with 3 mL of 0.08% pepsin, for 20 min at 37 1C. Samples were then pelleted by centrifugation and the supernatant was aspirated. Nuclei were resuspended, while being vortexed, with 1.5 mL 2 M HCl and incubated for 15 min at 37 1C. Twice the original sample volume of 0.1 M Sodium Borate was then added while vortexing. Nuclei were pelleted by centrifugation and the supernatant was aspirated. The resulting pellet was then resuspended, with continuous vortexing, in 2 mL IFA (150 mM NaCl, 4% fetal bovine serum, 0.1% sodium azide) plus 5% Tween20. Samples were once again pelleted by centrifugation and the supernatant was aspirated. Nuclei were stained with fluorescein isothiocyanate (FITC) conjugated anti-BrdU antibody (Becton Dickinson, Franklin Lakes, NJ), for 30 min on ice. Nuclei were pelleted, supernatant removed, and resulting pellet was resuspended in 250 mL of 5 mg/ml RNase A dissolved in IFA, transferred to 12 by 75-mm snap cap tubes, and incubated at 37 1C for 15 min. Following incubation, 250 mL of 100 mg propidium iodide (PI) per ml was added. Nuclei were then analyzed using a BD FACS Scan instrument (Becton Dickinson) and FlowJo software (Ashland, OR).
